Posted 2/27/2013 by hhill
Many of you are familiar with the Oncotype DX test, a genomic test that looks at groups of genes in breast cancer cells and predicts the odds of a recurrence. This test has been around since about 2005 and has been used for women who have a node negative, ER positive breast cancer and are trying to make a decision about chemotherapy. It has been very helpful in adding an important piece of information to this so difficult choice.
Read more...